ATE147267T1 - Verwendung von 24,25-dihydroxyvitamin-d3 zur herstellung eines arzneimittel zur behandlung der rachitis - Google Patents

Verwendung von 24,25-dihydroxyvitamin-d3 zur herstellung eines arzneimittel zur behandlung der rachitis

Info

Publication number: ATE147267T1
Authority: AT; Austria
Prior art keywords: treatment; rachitis; dihydroxyvitamin; producing; medicinal product
Prior art date: 1992-06-23

Application number

AT93110006T

Other languages

English (en)

Inventor

Yoshiki Seino

Hiroyuki Tanaka

Yumiko Nagai

Original Assignee

Kureha Chemical Ind Co Ltd

Yoshiki Seino

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1992-06-23

Filing date

1993-06-23

Publication date

1997-01-15

1993-06-23 Application filed by Kureha Chemical Ind Co Ltd, Yoshiki Seino filed Critical Kureha Chemical Ind Co Ltd

1997-01-15 Application granted granted Critical

1997-01-15 Publication of ATE147267T1 publication Critical patent/ATE147267T1/de

Links

208000007442 rickets Diseases 0.000 title abstract 2
FCKJYANJHNLEEP-XRWYNYHCSA-N (24R)-24,25-dihydroxycalciol Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@@H](CC[C@@H](O)C(C)(C)O)C)=C\C=C1\C[C@@H](O)CCC1=C FCKJYANJHNLEEP-XRWYNYHCSA-N 0.000 title 1
229940126601 medicinal product Drugs 0.000 title 1
FCKJYANJHNLEEP-SRLFHJKTSA-N 24,25-dihydroxycholecalciferol Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@@H](CCC(O)C(C)(C)O)C)=C\C=C1\C[C@@H](O)CCC1=C FCKJYANJHNLEEP-SRLFHJKTSA-N 0.000 abstract 1
208000037147 Hypercalcaemia Diseases 0.000 abstract 1
201000006035 X-linked dominant hypophosphatemic rickets Diseases 0.000 abstract 1
239000004480 active ingredient Substances 0.000 abstract 1
230000001749 antrachitic effect Effects 0.000 abstract 1
239000003795 chemical substances by application Substances 0.000 abstract 1
230000000694 effects Effects 0.000 abstract 1
230000000148 hypercalcaemia Effects 0.000 abstract 1
208000030915 hypercalcemia disease Diseases 0.000 abstract 1
208000011111 hypophosphatemic rickets Diseases 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1
239000000126 substance Substances 0.000 abstract 1
208000032349 type 2B vitamin D-dependent rickets Diseases 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
- A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Epidemiology (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Diabetes (AREA)
Hematology (AREA)
Obesity (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

AT93110006T 1992-06-23 1993-06-23 Verwendung von 24,25-dihydroxyvitamin-d3 zur herstellung eines arzneimittel zur behandlung der rachitis ATE147267T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
JP4188672A JP2876547B2 (ja)	1992-06-23	1992-06-23	抗クル病剤

Publications (1)

Publication Number	Publication Date
ATE147267T1 true ATE147267T1 (de)	1997-01-15

Family

ID=16227833

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT93110006T ATE147267T1 (de)	1992-06-23	1993-06-23	Verwendung von 24,25-dihydroxyvitamin-d3 zur herstellung eines arzneimittel zur behandlung der rachitis

Country Status (7)

Country	Link
US (1)	US5508274A (de)
EP (1)	EP0575974B1 (de)
JP (1)	JP2876547B2 (de)
KR (1)	KR940005277A (de)
AT (1)	ATE147267T1 (de)
DE (1)	DE69307197T2 (de)
DK (1)	DK0575974T3 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP4535174B2 (ja)	2008-07-11	2010-09-01	トヨタ自動車株式会社	車両の制御装置および制御方法
SG173119A1 (en) *	2009-01-27	2011-08-29	Berg Biosystems Llc	Vitamin d3 and analogs thereof for alleviating side effects associated with chemotherapy
MX366076B (es)	2009-08-14	2019-06-27	Berg Llc	Vitamina d3 y analogos de la misma para tratar alopecia.
SG10201709894RA (en)	2013-05-29	2018-01-30	Berg Llc	Preventing or mitigating chemotherapy induced alopecia using vitamin d

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3715374A (en)	1972-05-05	1973-02-06	Wisconsin Alumni Res Found	24,25-dihydroxycholecalciferol
US4021423A (en) *	1976-03-08	1977-05-03	Hoffmann-La Roche Inc.	Syntheses of 24R,25- and 24S,25-dihydroxycholecalciferol
US4028349A (en) *	1976-03-08	1977-06-07	Hoffmann-La Roche Inc.	Syntheses of 24R,25- and 24S,25-dihydroxycholesterol 24,25-ketals and alkanoyl derivatives thereof
US4224231A (en) *	1979-09-04	1980-09-23	Wisconsin Alumni Research Foundation	Derivatives of 25-hydroxycholecalciferol
IL74617A (en) *	1985-03-15	1988-11-15	Yeda Res & Dev	Compositions comprising a vitamin d derivative and method for the local treatment of bone fractures in animals
IL77668A (en) *	1986-01-21	1989-03-31	Teva Pharma	Production of cholecalciferol derivatives and novel intermediates used therefor
US5001118A (en) *	1986-12-29	1991-03-19	Kureha Kagaku Kogyo Kabushiki Kaisha	Method for preventing senescence and increasing bone mass
US4997824A (en) *	1987-07-22	1991-03-05	Teva Pharmaceutical Industries Ltd.	Combination of cholecalciferol derivatives for the treatment of renal bone disease
US4897388A (en) *	1988-12-20	1990-01-30	Geriatric Research Institute, Inc.	Method of treating Alzheimer's disease

1992
- 1992-06-23 JP JP4188672A patent/JP2876547B2/ja not_active Expired - Fee Related
1993
- 1993-06-22 KR KR1019930011405A patent/KR940005277A/ko not_active Ceased
- 1993-06-23 AT AT93110006T patent/ATE147267T1/de not_active IP Right Cessation
- 1993-06-23 DE DE69307197T patent/DE69307197T2/de not_active Expired - Fee Related
- 1993-06-23 DK DK93110006.9T patent/DK0575974T3/da active
- 1993-06-23 EP EP93110006A patent/EP0575974B1/de not_active Expired - Lifetime
1994
- 1994-11-08 US US08/338,790 patent/US5508274A/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
EP0575974A1 (de)	1993-12-29
US5508274A (en)	1996-04-16
KR940005277A (ko)	1994-03-21
DK0575974T3 (de)	1997-02-24
DE69307197T2 (de)	1997-04-24
JPH069406A (ja)	1994-01-18
EP0575974B1 (de)	1997-01-08
JP2876547B2 (ja)	1999-03-31
DE69307197D1 (de)	1997-02-20

Similar Documents

Publication	Publication Date	Title
ATE206919T1 (de)	2001-11-15	Verwendung des wirkstoffs flupirtin zur herstellung eines arzneimittels zur bekämpfung von muskelverspannungen
DE3684190D1 (de)	1992-04-16	Verwendung von tetrahydrobiopterinen zur herstellung eines medikaments zur behandlung von kinderautismus.
IL106562A0 (en)	1993-12-08	Pharmaceutical and/or cosmetic compositions and the use thereof
ZA92108B (en)	1992-10-28	Methods for preparation and use of 1alpha,24-dihydroxy vitamin d2
DE68912195D1 (de)	1994-02-24	Verwendung von Pyrrolicloncarbonsäurealkylestern zur Herstellung eines Arzneimittels zur Behandlung von Ichtyosis.
ATE141505T1 (de)	1996-09-15	Verwendung von 3-guanidinopropionsäure zur herstellung eines medikaments zur behandlung und prävention von fettsucht
ES2088959T3 (es)	1996-10-01	11-beta-aril-4-estreno, procedimiento para su preparacion y aplicacion como medicamento.
ATE143938T1 (de)	1996-10-15	Diphenylheteroalkylderivate, ihre herstellung und daraus hergestellte arzneimittel und kosmetika
DE59401401D1 (de)	1997-02-06	Pharmazeutische formulierung zur behandlung der nicotinabhängigkeit
DE3683333D1 (de)	1992-02-20	Mittel zur behandlung von akne vulgaris und deren herstellung.
ATE177950T1 (de)	1999-04-15	Verfahren zur herstellung eines arzneimittels zur oralen oder topischen verabreichung bei der behandlung von leishmaniasis
FR2713640B1 (fr)	1996-01-05	Nouveaux composés aromatiques polycycliques, compositions pharmaceutiques et cosmétiques les contenant et utilisations.
ATE123945T1 (de)	1995-07-15	Verwendung von fluor enthaltenden pyridoncarbonsäure-derivaten zur herstellung eines arzneimittels zur behandlung von hiv infektionen.
ATE135220T1 (de)	1996-03-15	Verwendung von 1-alpha,24(r)-dihydroxy-22(e)- dehydrovitamin-d3 zur herstellung eines arzneimittels zur behandlung der osteoporose
ATE167060T1 (de)	1998-06-15	Epidermis-wachstumsfaktor als arzneimittel zur wiederherstellung der neuronen der substantia nigra in der behandlung nervenzerstörender störungen
DE59207280D1 (de)	1996-11-07	Verfahren zur Herstellung von stabilen, hydrophilen oder ambiphilen Creme-Zubereitungen, enthaltend vesikuläre Bestandteile, und deren Verwendung
DE69307197D1 (de)	1997-02-20	Verwendung von 24,25-Dihydroxyvitamin-D3 zur Herstellung eines Arzneimittel zur Behandlung der Rachitis
AU7125991A (en)	1991-08-29	Novel antiulcer substance
DE69026511D1 (de)	1996-05-15	Verwendung von gibberellinen zur herstellung eines arzneimittels zur behandlung von prostatitis
ATE183088T1 (de)	1999-08-15	Arzneimittel zur behandlung von hauterkrankungen
ATE190484T1 (de)	2000-04-15	Arzneimittel zur behandlung von durch babesia verursachten protozoeninfektionen
GB9216859D0 (en)	1992-09-23	Medicaments
DE69424415D1 (de)	2000-06-15	Verwendung von efaroxan und dessen derivaten zur herstellung eines arzneimittels zur behandlung parkinsonscher krankheit
ATE179070T1 (de)	1999-05-15	Dithranol enthaltendes arzneimittel zur topischen anwendung sowie herstellungsverfahren
ATE173921T1 (de)	1998-12-15	Verwendung von deoxyspergualin zur herstellung eines arzneimittels zur behandlung von entzündlich-hyperreaktiven erkrankungen

Legal Events

Date	Code	Title	Description
1997-07-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties